PP
MRNA icon

Patten & Patten’s Moderna MRNA Stock Holding History

Patten & Patten’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,400
Closed -$210K – 329
2025
Q1 		$210K Sell
7,400
-103
-1% -$3.65K 0.01% 307
2024
Q4 		$312K Sell
7,503
-1,510
-17% -$72.2K 0.02% 258
2024
Q3 		$602K Sell
9,013
-181
-2% -$16.6K 0.04% 205
2024
Q2 		$1.09M Sell
9,194
-300
-3% -$38K 0.08% 156
2024
Q1 		$1.01M Buy
9,494
+671
+8% +$67.6K 0.07% 159
2023
Q4 		$877K Buy
8,823
+235
+3% +$19.8K 0.07% 157
2023
Q3 		$887K Sell
8,588
-907
-10% -$101K 0.08% 149
2023
Q2 		$1.15M Sell
9,495
-585
-6% -$78K 0.1% 138
2023
Q1 		$1.55M Sell
10,080
-51
-0.5% -$8.41K 0.14% 113
2022
Q4 		$1.82M Sell
10,131
-745
-7% -$122K 0.17% 99
2022
Q3 		$1.29M Sell
10,876
-574
-5% -$87.1K 0.12% 119
2022
Q2 		$1.64M Sell
11,450
-4
-0% -$572 0.14% 106
2022
Q1 		$1.97M Sell
11,454
-50
-0.4% -$8.42K 0.14% 109
2021
Q4 		$2.92M Sell
11,504
-160
-1% -$46.8K 0.2% 87
2021
Q3 		$4.49M Sell
11,664
-275
-2% -$101K 0.34% 76
2021
Q2 		$2.81M Buy
11,939
+2,449
+26% +$438K 0.21% 87
2021
Q1 		$1.24M Buy
9,490
+1,120
+13% +$162K 0.1% 130
2020
Q4 		$874K Buy
8,370
+110
+1% +$11.1K 0.08% 153
2020
Q3 		$584K Buy
8,260
+85
+1% +$5.93K 0.06% 166
2020
Q2 		$525K Buy
8,175
+80
+1% +$4.38K 0.06% 165
2020
Q1 		$242K Buy
+8,095
New +$186K 0.03% 205

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Patten & Patten's MRNA Position: Q2 2025 in Review

Patten & Patten sold out of Moderna (MRNA) in Q2 2025, closing a stake of 7,400 shares — an estimated $210K sold.

Patten & Patten first reported a position in MRNA in Q1 2020 and held it in 21 quarters. The position peaked at $4.49M in Q3 2021. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Patten & Patten reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Patten & Patten sold 7,400 Moderna shares in Q2 2025, an estimated $210K.
  • Patten & Patten first reported a position in Moderna in Q1 2020 and held it in 21 quarters.
  • Patten & Patten's Moderna position peaked at $4.49M in Q3 2021.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Patten & Patten's 13F filing for Q2 2025, filed 28 Jul 2025.